FDA Approved: LUTRATE DEPOT — Supplemental Application (Avyxa Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for LUTRATE DEPOT (leuprolide acetate) from Avyxa Pharma, LLC. This action updates the product’s labeling and/or indicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Central Precocious Puberty
• Endometriosis
• Prostate Cancer
• Uterine Fibroids

Drugs mentioned

• LUTRATE DEPOT (LEUPROLIDE ACETATE)

Snippet

SUPPL AP for LUTRATE DEPOT (LEUPROLIDE ACETATE)